Page 124 - Largest Global Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Nov 28, 2024

Discover large cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

3,223 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

GCAN

Greater Cannabis Company
US$0.000450%-52.6%US$362.1kn/aPE-2xn/an/a

MLCL

Molecule Holdings
n/an/an/aCA$488.9kn/an/an/an/a

IMPL.Q

IPI Legacy Liquidation Co
US$0.015-23.9%-98.9%US$358.5kn/aPE-0.005xn/an/a

KDCE

Kid Castle Educational
US$0.0160%-48.7%US$357.2kn/aPB0.1xn/an/a

SE

Sweet Earth Holdings
CA$0.02-20.0%-84.6%CA$496.1kn/aPE2.7xn/an/a

YTEN

Yield10 Bioscience
US$0.512.0%-92.4%US$353.3kn/aPE-0.03xn/an/a

MYCO.F

Mydecine Innovations Group
US$0.0054-21.7%-93.7%US$333.5kn/aPE-0.04xn/an/a

3YX

INDVR Brands
€0.0010%-50.0%€314.1kn/an/an/an/a

TCBP

TC Biopharm (Holdings)
US$0.60-3.8%-99.2%US$328.8kn/aPB0.2xn/an/a

ALVET

TheraVet
€0.0861.2%-94.7%€305.5kn/aPB0.06xn/an/a

PHCG

Pure Harvest Group
US$0.00260.0%42.9%US$318.8kn/an/an/an/a

DCNN

Digicann Ventures
CA$0.020%33.3%CA$441.1kn/aPE0.04xn/an/a

XSNX

NovAccess Global
US$0.005-44.4%-83.3%US$309.5kn/aPE-0.2xn/an/a

RIVU

Rivulet Media
US$0.00170%-57.5%US$304.8kn/an/an/an/a

LADX

LadRx
US$0.60-25.0%-63.4%US$297.1kn/aPE-0.1xn/an/a

BTI.H

Bioasis Technologies
CA$0.0050%-50.0%CA$397.1kn/an/an/an/a

ENDV

Endonovo Therapeutics
US$0.00070%-94.2%US$277.8kn/aPS1.1xn/an/a

CNBX

CNBX Pharmaceuticals
US$0.0087-14.7%-33.1%US$270.7kn/aPS1.2xn/an/a

ABRT

Albert Labs International
CA$0.0050%-50.0%CA$372.1kn/aPE-0.2xn/an/a

IPIX

Innovation Pharmaceuticals
US$0.0005150.0%-92.9%US$264.4kn/aPB0.2xn/an/a

LOWL

Lowell Farms
CA$0.020%-93.5%CA$363.0kn/aPB0.06xn/an/a

NSHS

NanoSphere Health Sciences
CA$0.03540.0%600.0%CA$359.6kn/aPE-1.3xn/an/a

WESA.X

Wesana Health Holdings
CA$0.010%0%CA$349.6kn/aPE-0.1xn/an/a

KAST

Kasten
US$0.0060%-85.8%US$246.8kn/an/an/an/a
Page 124 of 135
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.